Stock Events

Stock Events

Xeris Biopharma (XERS) Q4 2024 Earnings

8NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.14

-0.12

-0.1

-0.09

Details

Expected EPS

-0.086667

Actual EPS

-0.11

Surprise EPS

-0.02

Surprise Percent

+26.92%

Description

Xeris Biopharma (XERS) has reported earnings of -0.11 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.